3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2/3
1
Status
Unknown
2
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gynecologic
2
Conditions
Carcinoma, Non-Small-Cell Lung
44
Colorectal Neoplasms
22
Breast Neoplasms
22
Stomach Neoplasms
21
Neoplasms
18
Esophageal Squamous Cell Carcinoma
12
Neoplasm Metastasis
11
Nasopharyngeal Carcinoma
11
Lung Neoplasms
11
Rectal Neoplasms
9
Colonic Neoplasms
8
Pancreatic Neoplasms
7
Uterine Cervical Neoplasms
6
Esophageal Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Ovarian Neoplasms
5
Osteosarcoma
5
Brain Neoplasms
5
Small Cell Lung Carcinoma
4
Recurrence
4
Glioblastoma
4
Gastrointestinal Neoplasms
4
Precision Cell Immunotherapy
3
Melanoma
3
Lymphoma, Non-Hodgkin
3
Lymphoma
3
Head and Neck Neoplasms
3
Gastrointestinal Diseases
3
Digestive System Neoplasms
3
Carcinoma, Ovarian Epithelial
3
Interventions
Methotrexate
4
Vacuum Curettage
3
Drug Therapy
2
Dactinomycin
2
pembrolizumab
1
camrelizumab
1
Vincristine
1
Surgical Procedures, Operative
1
Paclitaxel
1
Leucovorin
1
Letrozole
1
Injections
1
Etoposide
1
Cyclophosphamide
1
Cisplatin
1
Carboplatin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Gestational Trophoblastic Disease
×
Drug Therapy
×
Clear all
NCT04756713
2022-05-27
ReCure
Brigham and Women's Hospital
Phase 3
Unknown
150 enrolled
NCT02606539
2017-03-22
SVCGTN
Mansoura University
Phase 2/3
Unknown
20 enrolled